Billing Code Overview

HCPCS Level II code J0177 describes the medication aflibercept hd, packaged as an injection, 1 mg. This code is used when aflibercept hd is supplied for ophthalmic use and administered via intravitreal injection. The service type associated with this code is Ophthalmology / Intravitreal injection. The typical site of service for procedures billed with this code is the Physician Office (POS 11).

Clinical Context

A 68-year-old patient with a history of diabetes mellitus presents to an ophthalmology clinic for worsening central vision and confirmed macular edema on optical coherence tomography. The ophthalmologist documents clinically significant macular edema related to diabetic retinopathy and recommends an intravitreal pharmacologic injection. The medication billed is HCPCS Level II code J0177 for injection, aflibercept hd, 1 mg. The procedure is performed in the physician office (POS 11) using standard intravitreal aseptic technique. Laterality is appended using modifier RT for the right eye or LT for the left eye when applicable. The intravitreal injection procedure code 67028 is reported separately for the injection service when required by payer billing rules.

Coding Specifications

• Modifiers

• RT — Right side (right eye): used when the injection is administered in the patient’s right eye.

• LT — Left side (left eye): used when the injection is administered in the patient’s left eye.

• Provider Taxonomies

• 174400000X — Ophthalmology: represents ophthalmologists providing evaluation and intravitreal therapeutic procedures.

• Notes on use

• HCPCS Level II code J0177 identifies the drug product (aflibercept hd, 1 mg) supplied for intravitreal administration.

• The intravitreal procedure itself is reported with 67028 (separate procedure) when payer policy requires a procedural code in addition to the drug HCPCS code.

Related Diagnoses

• E08.311 — Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema

• Clinical relevance: Documents diabetes-related retinopathy with macular edema as the systemic cause for macular fluid that may be treated with intravitreal aflibercept (J0177).

• E08.3211 — Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye

• Clinical relevance: Specifies mild nonproliferative diabetic retinopathy with macular edema in the right eye; supports laterality when billing J0177 with modifier RT.

• E08.3212 — Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye

• Clinical relevance: Specifies mild nonproliferative diabetic retinopathy with macular edema in the left eye; supports laterality when billing J0177 with modifier LT.

• E08.3213 — Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral

• Clinical relevance: Documents bilateral mild nonproliferative diabetic retinopathy with macular edema and may support billing of separate drug administrations for each eye using J0177 with appropriate laterality modifiers.

Related Codes

• 67028 — Intravitreal injection of a pharmacologic agent (separate procedure)

• Relationship to J0177:

• J0177 reports the drug product (aflibercept hd, 1 mg) administered intravitreally.

• 67028 reports the intravitreal injection procedure and is commonly billed on the same date of service as the drug HCPCS code when payer rules require separate reporting of the administration procedure.

• 67028 is commonly used together with HCPCS Level II code J0177 in the clinical workflow; no additional codes were provided.

National commercial mean rates for HCPCS Level II code J0177 generally exceed the BUCA average commercial mean of $329.57, with Aetna at $360.85 and UnitedHealthcare at $349.70. Medicare is not present in the provided input for direct comparison to commercial averages.

Rate dispersion (P75 minus P25) is tightest for Cigna Health (P75–P25 = $0.00) and relatively tight for BUCA (P75–P25 = $15.00) and Aetna (P75–P25 = $118.88). The widest dispersion appears for Blue Cross Blue Shield (P75–P25 = $27.00) and UnitedHealthcare (P75–P25 = $19.17). The table and chart below present the full breakdown.